Evidence map›Paper›PMID 37137878›Full record

ArticleBlood cancer journal2023

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.

Francesca Palandri, Elena M Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H Heidel, Simona Paglia, Malgorzata M Trawinska, Costanza Bosi, Elena Rossi and 34 more

Open access · goldAbstract readLetter
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 2 countries.

Francesca PalandriIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy. francesca.palandri@unibo.it.ORCID 0000-0001-8367-5668
Elena M ElliHematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
Giuseppe AuteriIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Massimiliano BonifacioSection of Hematology, Department of Medicine, University of Verona, Verona, Italy.ORCID 0000-0003-0716-1686
Giulia BenevoloHematology U, Department of Oncology, Città della Salute e della Scienza, Turin, Italy.
Florian H HeidelInnere Medicine C, Universitätsmedizin Greifswald, Greifswald, Germany.
Simona PagliaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.ORCID 0000-0002-5016-7840
Malgorzata M TrawinskaHematology, S.Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy.
Costanza BosiDivision of Hematology, AUSL di Piacenza, Piacenza, Italy.
Elena RossiSection of Hematology, Department of Radiological and Hematological Sciences, Catholic University School of Medicine, Rome, Italy.
Mario TiribelliDivision of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.ORCID 0000-0001-9449-2621
Alessia TieghiDepartment of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0002-6911-4095
Alessandra IurloHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-4401-0812
Nicola PolverelliUnit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili di Brescia, Brescia, Italy.ORCID 0000-0001-6297-9697
Giovanni CaocciHematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.ORCID 0000-0002-6585-5187
Gianni BinottoUnit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
Francesco CavazziniDivision of Hematology, University of Ferrara, Ferrara, Italy.
Eloise BeggiatoHematology U, Department of Oncology, Città della Salute e della Scienza, Turin, Italy.
Daniela CilloniHaematology Division, Department of Clinical and Biological Sciences, Ospedale San Luigi di Orbassano, University of Turin, Orbassano, Italy.
Caterina TatarelliHematology, S.Andrea Hospital, Rome, Italy.
Francesco MendicinoUnit of Hematology, Hospital of Cosenza, Cosenza, Italy.
Maurizio MiglinoIRCCS Policlinico San Martino, Genova, Italy.
Monica BocchiaHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
Monica CrugnolaDivision of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Camilla MazzoniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Andrea D RomagnoliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Giovanni RindoneHematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
Sara CeglieSection of Hematology, Department of Radiological and Hematological Sciences, Catholic University School of Medicine, Rome, Italy.
Alessandra D'AddioDivision of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy.
Eleonora SantoniSection of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Daniele CattaneoHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Daniela BartolettiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Roberto M LemoliIRCCS Policlinico San Martino, Genova, Italy.
Mauro KramperaSection of Hematology, Department of Medicine, University of Verona, Verona, Italy.ORCID 0000-0002-7280-2040
Antonio CuneoDivision of Hematology, University of Ferrara, Ferrara, Italy.
Gianpietro C SemenzatoUnit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.ORCID 0000-0002-6061-4595
Roberto LatagliataHematology Unit, Ospedale Belcolle, Viterbo, Italy.
Elisabetta AbruzzeseHematology, S.Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy.ORCID 0000-0001-5228-6491
Nicola VianelliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Michele CavoIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.ORCID 0000-0003-4514-3227
Alessandro AndrianiVilla Betania Hospital, Roma, Italy.
Valerio De StefanoSection of Hematology, Department of Radiological and Hematological Sciences, Catholic University School of Medicine, Rome, Italy.ORCID 0000-0002-5178-5827
Giuseppe A PalumboDipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Università degli Studi di Catania, Catania, Italy.ORCID 0000-0003-1859-6319
Massimo BrecciaA.O.U. Policlinico Umberto I, Università degli Studi di Roma "La Sapienza", Rome, Italy.ORCID 0000-0003-1163-6162
Istituto di Ematologia di Bologna · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Verona · ITASL Roma · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Ospedaliera San Gerardo · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITOspedale Policlinico San Martino · ITUniversity of Ferrara · ITUniversity of Padua · ITAzienda Ospedaliera di Cosenza · ITAzienda Sanitaria Unità Locale di Reggio Emilia · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITAzienda Unità Sanitaria Locale Della Romagna · ITAzienda Unità Sanitaria Locale Piacenza · ITCTO Andrea Alesini · ITOspedale di Belcolle · ITOspedale di Parma · ITOspedale San Luigi Gonzaga · ITOspedale Santa Maria della Misericordia di Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Myeloproliferative DisordersHumansNitrilesPyrazolesPyrimidinesNitrilesPyrazolesPyrimidinesruxolitinib

Identifiers

PMID37137878
PMCPMC10155661
OpenAlexW4368360289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.